These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 8011429

  • 1. Calyculin A and okadiac acid inhibit human platelet aggregation by blocking protein phosphatases types 1 and 2A.
    Nishikawa M, Toyoda H, Saito M, Morita K, Tawara I, Deguchi K, Kuno T, Shima H, Nagao M, Shirakawa S.
    Cell Signal; 1994 Jan; 6(1):59-71. PubMed ID: 8011429
    [Abstract] [Full Text] [Related]

  • 2. The effects of okadaic acid and calyculin A on thrombin induced platelet reaction.
    Murata K, Sakon M, Kambayashi J, Yukawa M, Ariyoshi H, Shiba E, Kawasaki T, Kang J, Mori T.
    Biochem Int; 1992 Feb; 26(2):327-34. PubMed ID: 1313673
    [Abstract] [Full Text] [Related]

  • 3. Inhibitors of protein phosphatase type 1 and 2A attenuate phosphatidylinositol metabolism and Ca(2+)-transients in human platelets. Role of a cdc2-related protein kinase.
    Lerea KM.
    Biochemistry; 1992 Jul 21; 31(28):6553-61. PubMed ID: 1321663
    [Abstract] [Full Text] [Related]

  • 4. The role of protein phosphatases 1 and 2A in collagen-platelet interaction.
    Chiang TM.
    Arch Biochem Biophys; 1993 Apr 21; 302(1):56-63. PubMed ID: 8385905
    [Abstract] [Full Text] [Related]

  • 5. The inhibitory effects of okadaic acid on platelet function.
    Higashihara M, Takahata K, Kurokawa K, Ikebe M.
    FEBS Lett; 1992 Jul 28; 307(2):206-10. PubMed ID: 1644174
    [Abstract] [Full Text] [Related]

  • 6. Aggregation-dependent signaling in human platelets is sensitive to protein serine/threonine phosphatase inhibitors.
    Hoyt CH, Lerea KM.
    Biochemistry; 1995 Jul 25; 34(29):9565-70. PubMed ID: 7626626
    [Abstract] [Full Text] [Related]

  • 7. Augmentation of retinoic acid-induced granulocytic differentiation in HL-60 leukemia cells by serine/threonine protein phosphatase inhibitors.
    Morita K, Nishikawa M, Kobayashi K, Deguchi K, Ito M, Nakano T, Shima H, Nagao M, Kuno T, Tanaka C.
    FEBS Lett; 1992 Dec 21; 314(3):340-4. PubMed ID: 1334850
    [Abstract] [Full Text] [Related]

  • 8. The possible involvement of protein phosphatase 1 in thrombin-induced Ca2+ influx of human platelets.
    Murata K, Sakon M, Kambayashi J, Yukawa M, Yano Y, Fujitani K, Kawasaki T, Shiba E, Mori T.
    J Cell Biochem; 1993 Apr 21; 51(4):442-5. PubMed ID: 8388395
    [Abstract] [Full Text] [Related]

  • 9. Cytoskeletal reorganization of human platelets induced by the protein phosphatase 1/2 A inhibitors okadaic acid and calyculin A.
    Yano Y, Sakon M, Kambayashi J, Kawasaki T, Senda T, Tanaka K, Yamada F, Shibata N.
    Biochem J; 1995 Apr 15; 307 ( Pt 2)(Pt 2):439-49. PubMed ID: 7733881
    [Abstract] [Full Text] [Related]

  • 10. Differential association of protein Ser/Thr phosphatase types 1 and 2A with the cytoskeleton upon platelet activation.
    Toyoda H, Nakai K, Omay SB, Shima H, Nagao M, Shiku H, Nishikawa M.
    Thromb Haemost; 1996 Dec 15; 76(6):1053-62. PubMed ID: 8972031
    [Abstract] [Full Text] [Related]

  • 11. Okadaic acid and vanadate inhibit collagen-induced platelet aggregation; the functional relation of phosphatases on platelet aggregation.
    Chiang TM.
    Thromb Res; 1992 Aug 15; 67(4):345-54. PubMed ID: 1384163
    [Abstract] [Full Text] [Related]

  • 12. Regulation of cytosolic PlA2 activity by PP1/PP2A serine/threonine phosphatases in human platelets.
    Moscardó A, Vallés J, Piñón M, Aznar J, Martínez-Sales V, Santos MT.
    Platelets; 2006 Sep 15; 17(6):405-15. PubMed ID: 16973502
    [Abstract] [Full Text] [Related]

  • 13. Phosphorylation and activation of phosphodiesterase type 3B (PDE3B) in adipocytes in response to serine/threonine phosphatase inhibitors: deactivation of PDE3B in vitro by protein phosphatase type 2A.
    Resjö S, Oknianska A, Zolnierowicz S, Manganiello V, Degerman E.
    Biochem J; 1999 Aug 01; 341 ( Pt 3)(Pt 3):839-45. PubMed ID: 10417351
    [Abstract] [Full Text] [Related]

  • 14. Calyculin A and okadaic acid: inhibitors of protein phosphatase activity.
    Ishihara H, Martin BL, Brautigan DL, Karaki H, Ozaki H, Kato Y, Fusetani N, Watabe S, Hashimoto K, Uemura D.
    Biochem Biophys Res Commun; 1989 Mar 31; 159(3):871-7. PubMed ID: 2539153
    [Abstract] [Full Text] [Related]

  • 15. Regulation of endothelial cell gap formation and barrier function by myosin-associated phosphatase activities.
    Verin AD, Patterson CE, Day MA, Garcia JG.
    Am J Physiol; 1995 Jul 31; 269(1 Pt 1):L99-108. PubMed ID: 7631821
    [Abstract] [Full Text] [Related]

  • 16. Role of type 1 and type 2A phosphatases in signal transduction of platelet-activating-factor-stimulated rabbit platelets.
    Murphy CT, Westwick J.
    Biochem J; 1994 Jul 15; 301 ( Pt 2)(Pt 2):531-7. PubMed ID: 8042999
    [Abstract] [Full Text] [Related]

  • 17. Calyculin A inhibits the exposure of fibrinogen receptor in thrombin-stimulated platelets.
    Sakon M, Murata K, Fujitani K, Yano Y, Kambayashi J, Uemura Y, Kawasaki T, Shiba E, Mori T.
    Biochem Biophys Res Commun; 1993 Aug 31; 195(1):139-43. PubMed ID: 8395822
    [Abstract] [Full Text] [Related]

  • 18. Platelet talin is phosphorylated by calyculin A.
    Murata K, Sakon M, Kambayashi J, Okuyama M, Hase T, Mori T.
    J Cell Biochem; 1995 Jan 31; 57(1):120-6. PubMed ID: 7721951
    [Abstract] [Full Text] [Related]

  • 19. Protein phosphatase inhibitor calyculin-A modulates activation markers in TRAP-stimulated human platelets.
    Simon Z, Kiss A, Erdödi F, Setiadi H, Beke Debreceni I, Nagy B, Kappelmayer J.
    Platelets; 2010 Jan 31; 21(7):555-62. PubMed ID: 20670106
    [Abstract] [Full Text] [Related]

  • 20. Okadaic acid inhibits activation of phospholipase C in human platelets by mimicking the actions of protein kinases A and C.
    Walker TR, Watson SP.
    Br J Pharmacol; 1992 Mar 31; 105(3):627-31. PubMed ID: 1628149
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.